Atypical progressive multifocal leukoencephalopathy (PML) in a patient with pulmonary sarcoidosis;Leucoencéphalopathie multifocale progressive atypique chez un patient atteint de sarcoïdose médiastinopulmonaire

Revue Neurologique

Volumn 166, Issue 3, 2010, Pages 341-345

  Le Guilloux, J ^a   Roubiou, C ^c   Mallet, J ^a   Bouvry, D ^a   Alkhalil, A ^a   Coman, I ^a   Belin, C ^a   Gorochov, G ^b   Carpentier, A ^b   Mokhtari, K ^b   Carpentier, A F ^a  

^a AVICENNE HOSPITAL   (France)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^c center hospitalier de Belfort Montbéliard   (France)

Author keywords

Contrast enhancement; Immunodepression; JC virus; Progressive multifocal leukoencephalopathy; Sarcoidosis

Indexed keywords

CIDOFOVIR; CYCLOPHOSPHAMIDE; HYDROXYCHLOROQUINE; METHYLPREDNISOLONE; PREDNISONE;

ADULT; ARTICLE; BRAIN BIOPSY; CASE REPORT; CONTRAST ENHANCEMENT; DISEASE ASSOCIATION; HUMAN; HUMAN TISSUE; IMMUNE DEFICIENCY; JC VIRUS; LABORATORY TEST; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; SARCOIDOSIS;

ADULT; BRAIN; DEMYELINATING DISEASES; HUMANS; IMMUNOHISTOCHEMISTRY; LEUKOENCEPHALOPATHY, PROGRESSIVE MULTIFOCAL; MAGNETIC RESONANCE IMAGING; MALE; SARCOIDOSIS, PULMONARY;

EID: 77649237739     PISSN: 00353787     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neurol.2009.05.015     Document Type: Article

References (32)

1. Antinori A., Cingolani A., Lorenzini P., et al. Clinical epidemiology and survival of progressive multifocal leukoencephalopathy in the era of highly active antiretroviral therapy: data from the Italian Registry Investigative Neuro AIDS (IRINA). J Neurovirol 9 Suppl. 1 (2003) 47-53
2. Arbusow V., Strupp M., Pfister H.W., Seelos K.C., Brückmann H., and Brandt T. Contrast enhancement in progressive multifocal leukoencephalopathy: a predictive factor for long-term survival?. J Neurol 247 (2000) 306-308
3. Astrom K.E., Mancall E.L., and Richardson E.P. Progressive multifocal leukoencephalopathy. A hitherto unrecognised complication of chronic lymphatic leukaemia and Hodgkin's disease. Brain 18 (1958) 93-111
4. Berger J.R., Kaszovitz B., Post M.J., and Dickinson G. Progressive multifocal leukoencephalopathy associated with human immunodeficiency virus infection. A review of the literature with a report of sixteen cases. Ann Intern Med 107 (1987) 78-87
5. Berger J.R., Pall L., Lanska D., and Whiteman M. Progressive multifocal leukoencephalopathy in patients with HIV infection. J Neuro Virol 4 (1998) 59-68
6. Berger J.R., Levy R.M., Flomenhoft D., and Dobbs M. Predictive factors for prolonged survival in acquired immunodeficiency syndrome-associated progressive multifocal leukoencephalopathy. Ann Neurol 44 (1998) 341-349
7. Brooks B.R., and Walker D.L. Progressive multifocal leukoencephalopathy. Neurol Clin 2 (1984) 299-313
8. Chapelon-Abric C. Neurosarcoidosis. Rev Neurol (Paris) 162 (2006) 1173-1188
9. Cinque P., Scarpellini P., Vago L., Linde A., and Lazzarin A. Diagnosis of central nervous system complications in HIV-infected patients: cerebrospinal fluid analysis by polymerase chain reaction. AIDS 11 (1997) 1-17
10. De Raedt S, Lacor P, Michotte A, Flamez A, Ebinger G. Progressive multifocal leukoencephalopathy as first manifestation of sarcoidosis. Clin Neurol Neurosurg, 110:186-9. Neurology 2008;71:766-73.
11. Gasnault J., and Taoufik Y. New trends in progressive multifocal leukoencephalopathy. Rev Neurol (Paris) 162 (2006) 43-56
12. Goodin D.S., Cohen B.A., O'Connor P., Kappos L., and Stevens J.C. Assessment: the use of natalizumab (Tysabri) for the treatment of multiple sclerosis (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 71 (2008) 766-773
13. Hutchinson M. Natalizumab: a new treatment for relapsing remitting multiple sclerosis. Ther Clin Risk Manag 3 (2007) 259-268
14. Krupp L.B., Lipton R.B., Swerdlow M.L., Leeds N.E., and llena J. Progressive multifocal leukoencephalopathy: clinical and radiographic features. Ann Neurol 17 (1985) 344-349
15. Küker W., Mader I., Nägele T., Uhl M., Adolph C., Klose U., et al. Progressive multifocal leukoencephalopathy: value of diffusion-weighted and contrast-enhanced magnetic resonance imaging for diagnosis and treatment control. Eur J Neuro 13 (2006) 819-826
16. Iannarella G., Makdassi R., Schmit J.L., Gontier M.F., Legars D., Deramond H., et al. Association of progressive multifocal leukoencephalitis and sarcoidosis. Ann Med Int (Paris) 143 (1992) 71-74
17. Larnaout A., Haddad M., Hentati F., and Ben Hamida M. Candida albicans meningitis and neurosarcoidosis. Rev Neurol (Paris) 148 (1992) 762-768
18. Mackowiak-Cordolianin M.A., De Seze J., Stojkovic T., Ferriby D., Ingrand D., and Vermersch P. Sarcoidosis and progressive multifocal leukoencephalopathy. Rev Neurol (Paris) 157 (2001) 547-550
19. Manji H., and Miller R.F. Progressive multifocal leukoencephalopathy: progress in the AIDS era. J Neurol Neurosurg Psychiatry 69 (2000) 569-571
20. Mariott P.J., O'Brien M.D., Mackenzie I.C., and Janota I. Progressive multifocal leukoencephalopathy: remission with cytarabine. J Neurol Neurosurg Psychiatry 38 (1975) 205-209
21. Mark A.S., and Atlas S.W. Progressive multifocal leukoencephalopathy in patients with AIDS: appareance on MR images. Radiology 173 (1989) 517-620
22. Matsushima T., Nakamura K., Oka T., Tachikawa N., Sata T., Murayama S., et al. Unusual MRI and pathologic findings of progressive multifocal leukoencephalopathy complicating adult Wiskott-Aldrich syndrome. Neurology 48 (1997) 279-282
23. McGuire D., Barhite S., Hollander H., and Miles M. JC virus DNA in cerebrospinal fluid of human immunodeficiency virus-infected patients: predictive value for progressive multifocal leukoencephalopathy. Ann Neurol 37 (1995) 395-399
24. Miyara M., Amoura Z., Parizot C., Badoual C., Dorgham K., Trad S., et al. The immune paradox of sarcoidosis and regulatory T cells. J Exp Med 203 (2006) 359-370
25. Olindo S., Guillon B., Faighel M., and Feve J.R. Progressive multifocal leukoencephalopathy and pulmonary sarcoidosis. Rev Neurol (Paris) 156 (2000) 1013-1016
26. Olsen W.L., Longo F.M., Millis C.M., and Norman D. White matter disease in AIDS: findings in MR imaging. Radiology 169 (1998) 445-448
27. Power C., Gladden J.G., Halliday W., Del Bigio M.R., Nath A., Ni W., et al. AIDS- and non-AIDS-related PML association with distinct p53 polymorphism. Neurology 54 (2000) 743-746
28. Rosenbloom M.A., and Uphoff D.F. The association of progressive multifocal leukoencephalopathy and sarcoidosis. Chest 83 (1983) 572-575
29. Weber T., Frye S., Bodemer M., Otto M., and Lüke W. Clinical implications of nucleic acid amplification methods for the diagnosis of viral infections of the nervous system. J Neurovirol 2 (1996) 175-190
30. Wheeler A.L., Truwit C.L., Kleinschmidt-Demasters B.K., Byrne W.R., and Hannon R.N. Progressive multifocal leukoencephalopathy: contrast enhancement on CT scans and MR images. AJR Am J Roentgenol 161 (1993) 1049-1050
31. Whiteman M.L., Post M.J., Berger J.R., Tate L.G., Bell M.D., and Limonte L.P. Progressive multifocal leukoencephalopathy in 47 HIV-seropositive patients: neuroimaging with clinical and pathologic correlation. Radiology 187 (1993) 233-240
32. Wiley C.A., and Nelson J.A. Role of HIV and CMV in AIDS encephalitis. Am J Pathol 133 (1988) 73-81